ArticleTheranostics2024
Reprogramming Exosomes to Escape from Immune Surveillance for Mitochondrial Protection in Hepatic Ischemia-Reperfusion Injury.
Open access · goldAbstract read
In one paragraph
Article in Theranostics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 21 citations in OpenAlex.
- Ferroptosis bridges early-life oxidative stress and lifetime meat quality defects in broilers.Poultry science · 2026Article
- Mitophagy in Hepatic Ischemia-Reperfusion Injury: From Mitochondrial Dysfunction to Therapeutic Targeting.Biomolecules · 2026Review
- Dual-loaded homotypic exosomes with endogenous IR808 and pH-responsive DOX drive sequenced chemo-PDT and convert "cold" OSCC tumors "hot".Journal of nanobiotechnology · 2026Article
- Novel perspectives on extracellular vesicles in autoimmune diseases: immunogenicity, inflammation, and immune surveillance.The Journal of clinical investigation · 2026Review
- Integrated transcriptomic profiling of programmed cell death patterns unveils macrophage-hepatocyte crosstalk via THBS1-CD47 axis in hepatic ischemia-reperfusion injury.Frontiers in immunology · 2026Article
- Emerging nanomedicine for liver diseases treatment.Journal of nanobiotechnology · 2025Review
- Progress of research on engineered extracellular vesicles from different sources for disease treatment.Histology and histopathology · 2025Review
- The cutting-edge progress of novel biomedicines in ovulatory dysfunction therapy.Acta pharmaceutica Sinica. B · 2025Review
- Exosomes derived from human umbilical cord mesenchymal stem cells attenuate hepatic ischaemia-reperfusion injuryWorld journal of gastroenterology · 2025Article
- Engineering the future of nanomedicine: Strategic approaches to extracellular vesicle-based drug administration regimens.World journal of stem cells · 2025Review
- Beyond cancer: The potential application of CD47-based therapy in non-cancer diseases.Acta pharmaceutica Sinica. B · 2025Review
- CKS2 Mediates Hepatocellular Carcinoma Recurrence After Hepatic Ischemia-Reperfusion Injury Related to M2 Macrophages.Journal of inflammation research · 2025Article
- Synergistic integration of extracellular vesicles and metal-organic frameworks: unlocking new opportunities in disease diagnosis and therapy.Theranostics · 2025Review
- Current state of heart failure treatment: are mesenchymal stem cells and their exosomes a future therapy?Frontiers in cardiovascular medicine · 2025Review
- Research Advances and Application Progress on miRNAs in Exosomes Derived From M2 Macrophage for Tissue Injury Repairing.International journal of nanomedicine · 2025Review
- Extracellular vesicles for delivering therapeutic agents in ischemia/reperfusion injury.Asian journal of pharmaceutical sciences · 2024Article
- Exosome-related gene identification and diagnostic model construction in hepatic ischemia-reperfusion injury.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 5 institutions in 1 country.
Shanshan LiuSchool of Basic Medical Science, Chongqing Medical University, Chongqing 400016, P. R. China.
Xinyu XiaoSchool of Basic Medical Science, Chongqing Medical University, Chongqing 400016, P. R. China.
La ZhangDepartment of Hepatobiliary Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P. R. China.
Jianwei WangSchool of Basic Medical Science, Chongqing Medical University, Chongqing 400016, P. R. China.
Wei ZhaoSchool of Basic Medical Science, Chongqing Medical University, Chongqing 400016, P. R. China.
Haichuan LiuDepartment of Hepatobiliary Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P. R. China.
Rui LiaoDepartment of Hepatobiliary Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P. R. China.
Zhi LiTraditional Chinese Medicine Hospital of Bijie City, Guizhou province, 551700, People's Republic of China.
Mengxia XuTraditional Chinese Medicine Hospital of Bijie City, Guizhou province, 551700, People's Republic of China.
Jiao GuoSchool of Basic Medical Science, Chongqing Medical University, Chongqing 400016, P. R. China.
Baoyong ZhouDepartment of Hepatobiliary Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P. R. China.
Chengyou DuDepartment of Hepatobiliary Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P. R. China.
Qiling PengSchool of Basic Medical Science, Chongqing Medical University, Chongqing 400016, P. R. China.
Ning JiangDepartment of Pathology, Chongqing Medical University, Chongqing 400016, P. R. China.
Chongqing Medical University · CNThe Affiliated Yongchuan Hospital of Chongqing Medical University · CNGuizhou Provincial People's Hospital · CNBeijing Municipal Health Commission · CNDalian Medical University · CN
Funding
Creative Research Group of CQ University CXQT21017National Natural Science Foundation of China GRANT NO. 81972023, GRANT NO. 82203310Natural Science Foundation of Chongqing City GRANT NO. CSTC2020JCYJ-MSXMX0144, CSTC2021JCYJ-MSXM0172, AND CSTB2022NSCQ-MSX0054Science and Technology Research Program of Chongqing Education Commission of China KJQN201900425 AND KJQN202000401
Abstract
PubMed holds no abstract for this paper.
Indexed as
ExosomesMicroRNAsReperfusion InjuryCD47 AntigenHumansMitochondriaMitochondrial Membrane Transport ProteinsCD47 AntigenMicroRNAsMitochondrial Membrane Transport ProteinsCD47Cyclosporin AExosomesHepatic ischemia/reperfusion injuryMacrophagesMitochondria
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.